PR Newswire - HSA approves GSK's Arexvy, the world's first respi...
Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by re...
Read More

ภาษาไทย
English